Product NDC: | 36987-1606 |
Proprietary Name: | Okra |
Non Proprietary Name: | Okra |
Active Ingredient(s): | .05 g/mL & nbsp; Okra |
Administration Route(s): | INTRADERMAL; SUBCUTANEOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 36987-1606 |
Labeler Name: | Nelco Laboratories, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | BLA102192 |
Marketing Category: | BLA |
Start Marketing Date: | 19720829 |
Package NDC: | 36987-1606-1 |
Package Description: | 5 mL in 1 VIAL, MULTI-DOSE (36987-1606-1) |
NDC Code | 36987-1606-1 |
Proprietary Name | Okra |
Package Description | 5 mL in 1 VIAL, MULTI-DOSE (36987-1606-1) |
Product NDC | 36987-1606 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Okra |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRADERMAL; SUBCUTANEOUS |
Start Marketing Date | 19720829 |
Marketing Category Name | BLA |
Labeler Name | Nelco Laboratories, Inc. |
Substance Name | OKRA |
Strength Number | .05 |
Strength Unit | g/mL |
Pharmaceutical Classes | Non-Standardized Plant Allergenic Extract [EPC],Non-Standardized Food Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [Chemical/Ingredient],Dietary Proteins [Chemical/Ingredient],Plant Proteins [Chemical/Ingredient] |